Week of August 15, 2023 | Vol. 12, Issue 32

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs

Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Novo Nordisk completes acquisition of Inversago Pharma for over $1 billion and announces remarkable megablockbuster sales of Wegovy

Biotecnika- Aug 10, 2023

HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.

Yahoo Finance - Aug 14, 2023

Roivant CEO hints at more deals shaping up as key Immunovant data loom

Endpoints News - Aug 14, 2023

HHS Urges Judge to Toss Chamber's Drug Price Negotiation Lawsuit

Bloomberg law - Aug 12, 2023

FDA hands Pfizer accelerated approval for myeloma therapy

Beckers Hospital Review - Aug 14, 2023

More hospital pharmacists are rationing drugs due to increasing shortages

Stat News - Aug 11, 2023

Obesity drug data could boost companies' case for US coverage

Reuters - Aug 10, 2023

Novo Nordisk's semaglutide injection reduces cardiovascular events by 20% in vast SELECT trial

Endpoints News - Aug 8, 2023

TANNER NEWS

Global access programs: meeting urgent medical needs

The mission of Tanner’s global access programs (GAP) division is to meet immediate medical needs for patients regardless of their geographical location. The division’s work includes addressing medicine market withdrawal, post-clinical trial solutions, mitigating drug shortages and managing medicine supply on a Named Patient basis. Learn more.